Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Journal of Immunotoxicology|March 9, 2010
High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic featuresE M Weiss, S Meister, C Janko, et al.Journal of Public Health Management and Practice : JPHMP|August 15, 2002
Building community capacity in public health: the role of action-oriented partnershipsM A Veazie, N I Teufel-Shone, G S Silverman, et al.Scientific Reports|June 26, 2019
HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinomaKara S Meister, Neal R Godse, Nayel I Khan, et al.Preventing Chronic Disease|September 19, 2007
From program to policy: expanding the role of community coalitionsAnne Hill, Jill Guernsey De Zapien, Lisa K Staten, et al.Research Square|February 24, 2023
Programmable RNA detection with CRISPR-Cas12aSantosh R Rananaware, Emma K Vesco, Grace M Shoemaker, et al.Biorxiv : the Preprint Server for Biology|February 13, 2023
Programmable RNA detection with CRISPR-Cas12aSantosh R Rananaware, Emma K Vesco, Grace M Shoemaker, et al.Nature Communications|September 5, 2023
Programmable RNA detection with CRISPR-Cas12aSantosh R Rananaware, Emma K Vesco, Grace M Shoemaker, et al.Scientific Reports|December 19, 2023
Characterization and prognostic impact of ACTBL2-positive tumor-infiltrating leukocytes in epithelial ovarian cancerN E Topalov, D Mayr, C Kuhn, et al.Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
DNA-guided CRISPR/Cas12 for RNA targetingCarlos Orosco, Santosh R Rananaware, Boyu Huang, et al.Nature Biotechnology|May 15, 2026
DNA-guided CRISPR-Cas12 for cellular RNA targetingCarlos Orosco, Boyu Huang, Santosh R Rananaware, et al.Pageof 5